Individual Disclosures for the NCCN Guidelines Panel for Lung Cancer Screening

Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
George A. Eapen, MD	None	None	None	None	17/20/11
David S. Ettinger, MD	None	Boehringer Ingelheim GmbH; Eli Lilly and Company; Genentech, Inc.; and Biodesix	None	None	6/13/11
Lifang Hou, MD, PhD	None	None	None	None	9/9/11
David M. Jackman, MD	None	Genentech, Inc.; and Foundation Medicine, Inc.	None	None	7/20/11
Ella Kazerooni, MD	None	None	None	None	7/21/11
Donald Klippenstein, MD	None	None	None	None	3/28/11
Rudy P. Lackner, MD	None	None	None	None	7/26/11
Lorriana Leard, MD	None	None	None	None	9/9/11
Ann N.C. Leung, MD	None	None	None	None	3/15/11
Pierre P. Massion, MD	None	None	None	None	9/9/11
Bryan F. Meyers, MD, MPH					Pending
Reginald F. Munden, MD, DMD, MBA	None	None	None	None	7/20/11
Gregory A. Otterson, MD	Abraxis Oncology; Boehringer Ingelheim GmbH; Celgene Corporation; Eli Lilly and Company; Genentech, Inc.; Pfizer Inc.; and Pharmacyclics, Inc.	Abraxis Bioscience, Inc.; and Genentech, Inc.	None	None	6/21/11
Kimberly Peairs, MD	None	None	None	None	7/15/11
Sudhakar Pipavath, MD	GE Healthcare	None	None	None	11/19/10
Christie Pratt-Pozo, MA, DHSc	None	None	None	None	9/9/11
Chakravarthy Reddy, MD	None	None	None	None	11/9/11
Mary E. Reid, PhD	None	None	None	None	7/26/11
Arnold J. Rotter, MD	None	None	None	None	7/21/11
Matthew B. Schabath, PhD	None	None	None	None	3/31/11
Lecia V. Sequist, MD, MPH	None	None	None	None	12/7/10
Betty C. Tong, MD, MHS	None	None	None	None	7/22/11
William D. Travis, MD	None	None	None	None	7/26/11
Michael Unger, MD, FCCP	None	None	None	None	9/12/11
Douglas E. Wood, MD	None	None	None	None	4/5/11
Stephen C. Yang, MD	None	None	None	None	5/26/11